MedTrace Logo

Pilot Study Evaluating the Safety and Efficacy of a New Hard-on-Hard Total Hip Replacement System

NCT02154516 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2024-12-06

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the early and long term safety and efficacy of the hard-on-hard total hip replacement system (R3 ODH-ODH utilization) in patients with non-inflammatory arthritis.

Conditions

  • Arthritis, Degenerative

Interventions

DEVICE

ODH Hip System

Sponsors & Collaborators

  • Smith & Nephew, Inc.

    lead INDUSTRY

Principal Investigators

  • Andrew Baker · Entabeni Hospital

  • Johannes de Beer · Zuid Afrikaans Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-04
Primary Completion
2022-10-18
Completion
2022-10-18

Countries

  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02154516 on ClinicalTrials.gov